Debt - News

Cheplapharm's Zyprexa Acquisition Debt Is Neutral to Rating – Fitch Ratings

April 24, 2023
0 75 Less than a minute


Cheplapharm’s Zyprexa Acquisition Debt Is Neutral to Rating  Fitch Ratings


Source link

April 24, 2023
0 75 Less than a minute

Related Articles

Is Smith Micro Software (NASDAQ:SMSI) Using Debt Sensibly? – Simply Wall St

January 31, 2024

Alpha Metallurgical Resources (NYSE:AMR) Seems To Use Debt Quite Sensibly – Simply Wall St

January 31, 2024

Service Corporation International (NYSE:SCI) Use Of Debt Could Be Considered Risky – Simply Wall St

January 31, 2024

Instructure Holdings (NYSE:INST) Seems To Use Debt Quite Sensibly – Simply Wall St

January 31, 2024

Leave a Reply

Your email address will not be published.

Back to top button